FLUO.ST FluoGuide A/S

P/E --
Forward P/E -4.9758453
Price/Sales 2122.6628
Beta --
Div Yield --
Market Cap --

Company Analysis

Latest News

🔴 FLUO.ST is trading 7.4% down today in a speculative whipsaw after recent gains

FLUO.ST is trading 7.4% down today at $36.10 in what appears to be a speculative whipsaw following recent sharp volatility. • The move follows a double-digit...

🟢 FLUO.ST is trading 10.2% up today with no clear catalyst identified

FLUO.ST is trading 10.2% up today at $43.30 with no clear catalyst identified, following a period of high price volatility. • The jump appears to be a...

🟢 FLUO.ST is trading 7.2% up today after reaffirmed 2026 outlook and trial update

FLUO.ST is trading at 7.2% up now at SEK 41.60 after the company reaffirmed its 2026 financial outlook and updated timelines for its lead cancer imaging drug...

FluoGuide Reaffirms 2026 Outlook, Pushes FG001 Cancer Trial Results to 2027

FluoGuide Reaffirms 2026 Outlook, Pushes FG001 Cancer Trial Results to 2027

FluoGuide A/S reaffirmed its 2026 financial outlook and confirmed overall progress remains on track. The company adjusted interim milestones for its lead...

FluoGuide's Cancer-Imaging Drug Hits a Milestone, So Why Are Shares Sliding Nearly 10%?

FluoGuide's Cancer-Imaging Drug Hits a Milestone, So Why Are Shares Sliding Nearly 10%?

Shares of FluoGuide A/S dropped sharply to $38.10, a 9.3% decline from recent highs, even as the Danish biotech announced its fluorescent imaging agent cleared...

🔴 FLUO.ST is trading 9.3% down today on profit-taking after early-stage Phase 2 trial results

FLUO.ST is trading 9.3% down at $38.10 as investors digest positive but early-stage Phase 2 data for its lead imaging agent, FG001. • The company announced...

FluoGuide Hits Phase 2 Milestone, Identifying Optimal Dose for Cancer Surgery

FluoGuide Hits Phase 2 Milestone, Identifying Optimal Dose for Cancer Surgery

FluoGuide A/S met the primary endpoint in the initial part of its Phase 2 clinical trial for FG001. The study successfully identified 0.30 mg/kg as the optimal...

🔴 FluoGuide A/S is trading 6.47% down

FLUO.ST is trading at $39.00, down 6.47%.

🟢 FLUO.ST Surges 9% Following Analyst Forecast of 2027 Profitability

FLUO.ST is trading 9% up at $45.40, driven by a recent analyst forecast. • An analyst, as reported on June 28, 2026, revised expectations for Fluoguide A/S,...

🔴 FLUO.ST is trading 6.3% down today amid broader market weakness

FLUO.ST is trading 6.3% down at $40.20 today as the stock experiences an unresolved selloff amid a mixed-to-weaker broader market backdrop. • The stock...

🔴 FLUO.ST is trading 5.3% down today as it reverses its recent rebound

FLUO.ST is trading 5.3% down today at $43.00, reversing its recent mid-June rebound amid a broader risk-off tone in global equities. • The move comes despite...